Open post

TransQST poster at the EUROTOX conference

TransQST poster at the EUROTOX in Brussels (Belgium) in September 2018

A poster of the TransQST work contributed by the University of Maastricht partner to the project was presented at the EUROTOX, 2-5th September in Brussels. In addition to the poster session participation, UM colleagues were also invited to present this poster in the Astrazeneca Educational Event, organized in the framework of the conference on the […]

Read moreMore Tag
Open post

2nd General Assembly Meeting

TransQST GAM2 will take place in Paris (France) in October 2018

The 2nd General Assembly Meeting will take place on the 17th and 18th of October 2018, at the Chilly Mazarin center of Sanofi pharma in Paris (France). The first day will be devoted to WPs workshops in parallel; and the second day, all consortium partners will meet for general updates presentations and future plans discussions. […]

Read moreMore Tag
Open post

The TXG-rMAP, an innovative WGCNA tool

UL partner presents their WGCNA tool

The Research Division of Drug Discovery and Safety of the University of Leiden (UL) participates to TransQST consortium. Bob van de Water lab team has mined the data of TG-GATEs database on primary human hepatocytes gene expression data and established WGCNA modules. These modules are available in an open source application  tool called TXG-rMAP. Co-regulated […]

Read moreMore Tag
Open post

TransQST at the IMI 10th anniversary

TransQST posters at the IMI 10th anniversary scientific symposium in October 2018

TransQST got acceptation of two abstracts submitted for the IMI 10th anniversary scientific symposium that will take place in Brussels on the 22nd and 23rd of October of 2018. ULIV and FIMIM partners will present their work within TransQST project in two posters presentations entitled as follows: IMIM – Network-based modeling of APAP-induced hepatotoxicity using […]

Read moreMore Tag
Open post

TransQST at Drug Safety GRC

TransQST participants attend the 2018 Drug Safety Gordon Research Conference

The TransQST project was well represented at the recent Drug Safety Gordon Research Conference (program).  The meeting addressed contemporary issue in drug safety spanning discovery to post-marketing surveillance with several sessions focused on translational safety and systems modeling.   Jim Stevens (Lilly/Leiden) Chaired the meeting.  Blanca Rodriguez (Oxford) gave a GRC plenary lecture titled, “Computational Modeling […]

Read moreMore Tag
Open post

TransQST Early Review

TransQST Early Review in Brussels (Belgium) in June 2018

On the 14th of June, TransQST consortium presented the progress of the project in the Early Review meeting that took place at the IMI premises The objective of this early review was to show up the strategy defined for the whole consortium to accomplish the goals of the project proposal and to give update on […]

Read moreMore Tag
Open post

TransQST meets eTRANSAFE

TransQST meets eTRANSAFE in Barcelona (Spain) in June 2018

On the 5th of June, TransQST project was presented in the 3rd consortium meeting of the IMI eTRANSAFE project. Professor Bob van de Water, from University of Leiden, presented the TransQST project to the eTRANSAFE consortium in their 3rd consortium meeting held on the 4-5th of June in Barcelona. Both IMI projects work in the […]

Read moreMore Tag
Open post

1st General Assembly Meeting

TransQST GAM1 took place in Vihti (Finland) in April 2018

The first General Assembly meeting, GAM1, took place on the 25th and 26th of April 2018, in Vihti at Orion Tuohilampi Training Center (Finland). This 2-day meeting was organized as follows: Day 1 – paralel meetings of Organ related WPs with representatives of WP3 (data) and WP4 (modelling), and Day 2 – whole consortium meeting […]

Read moreMore Tag
Open post

UOXF TransQST colleagues won the 2017 NC3Rs Prize

An in silico model that predicts cardiotoxicity awarded in March 2018

On the 12th of March 2018, the National Centre for the 3Rs (NC3Rs) – an organisation dedicated to replacing, refining and reducing the use of animals in research and testing – has awarded its top prize for a research paper on an in silico model that predicts cardiotoxicity developed and reported by the TransQST team […]

Read moreMore Tag
Open post

Boehringer Ingelheim joins the TransQST consortium

Boehringer Ingelheim has joined the consortium, effective since July 2017

The Boehringer Ingelheim (BI) pharmaceutical company made a formal proposal to join the TransQST consortium in June 2017. The TransQST partners found their addition to be an excellent opportunity to complement and extend the coverage of the modeling framework within the particular area of GI toxicity assessment (WP8). SYNAPSE has coordinated the documentation preparation between […]

Read moreMore Tag